Direct antiviral agents against hepatitis C virus: Beneficial or harmful?

被引：0
|
作者：
Murcia, Oscar [1 ]
Carnicer, Fernando [1 ]
Gomez-Escolar, Laura [2 ]
Miralles, Cayetano [3 ]
Pilar Grino, Maria [4 ]
Barquero Martin, Claudia [5 ]
Pascual, Sonia [1 ]
机构：
[1] Hosp Gen Univ Alicante, Dept Hepatol, Alicante, Spain
[2] Hosp Marina Baixa, Dept Hepatol, Villajoyosa, Spain
[3] Hosp Vinalopo, Dept Hepatol, Elche, Spain
[4] Hosp San Juan Alicante, Dept Hepatol, Alicante, Spain
[5] Hosp Gen Torrevieja, Dept Hepatol, Alicante, Spain
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 04期
关键词：
INTERFERON-FREE THERAPY; EARLY TUMOR RECURRENCE; HEPATOCELLULAR-CARCINOMA; HCC; RISK;
D O I：
10.1016/j.jhep.2017.10.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：844 / 845
页数：2
相关论文
共 50 条
  • [31] Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
    Ghweil, Ali A.
    Helal, Mohamad M.
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 759 - 762
  • [32] Association of serum interferon-λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agents
    Inoue-Shinomiya, Emi
    Murakawa, Miyako
    Asahina, Yasuhiro
    Nakagawa, Mina
    Tsuchiya, Jun
    Sato, Ayako
    Tsunoda, Tomoyuki
    Miyoshi, Masato
    Nitta, Sayuri
    Kawai-Kitahata, Fukiko
    Itsui, Yasuhiro
    Azuma, Seishin
    Kakinuma, Sei
    Murata, Kazumoto
    Mizokami, Masashi
    Watanabe, Mamoru
    HEPATOLOGY RESEARCH, 2019, 49 (05) : 500 - 511
  • [33] Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients
    Nogueras Lopez, F.
    Lopez Garrido, A.
    Ortega Suazo, E. J.
    Vadillo Galles, F.
    Valverde Lopez, F.
    Espinosa Aguilar, M. D.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (02) : 631 - 633
  • [34] Effects of Hepatitis C Virus Elimination by Direct-Acting Antiviral Agents on the Occurrence of Oral Lichen Planus and Periodontal Pathogen Load: A Preliminary Report
    Nagao, Yumiko
    Tsuji, Masahide
    INTERNATIONAL JOURNAL OF DENTISTRY, 2021, 2021
  • [35] Hepatocellular carcinoma after direct-acting antiviral drug treatment in patients with hepatitis C virus
    Kogiso, Tomomi
    Sagawa, Takaomi
    Kodama, Kazuhisa
    Taniai, Makiko
    Katagiri, Satoshi
    Egawa, Hiroto
    Yamamoto, Masakazu
    Tokushige, Katsutoshi
    JGH OPEN, 2019, 3 (01): : 52 - 60
  • [36] Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy
    Amaddeo, Giuliana
    Nguyen, Cong Trung
    Maille, Pascale
    Mule, Sebastien
    Luciani, Alain
    Machou, Camilia
    Rodrigues, Aurelie
    Regnault, Helene
    Mallat, Ariane
    Laurent, Alexis
    Lafdil, Fouad
    Hezode, Christophe
    Pawlotsky, Jean-Michel
    Calderaro, Julien
    LIVER INTERNATIONAL, 2020, 40 (01) : 74 - 82
  • [37] Impact of antiviral therapy with direct acting antiviral agents (DAAs) on kidney disease in patients with chronic hepatitis C
    Fabrizi, Fabrizio
    Cerutti, Roberta
    Alfieri, Carlo M.
    Ridruejo, Ezequiel
    MINERVA GASTROENTEROLOGY, 2021, 67 (03): : 244 - 253
  • [38] Direct antiviral agents in hepatitis C virus related liver disease: Don't count the chickens before they're hatched
    Compagnoni, Stella
    Bruno, Erica Maria
    Madonia, Giorgio
    Cannizzaro, Marco
    Madonia, Salvatore
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (21) : 2771 - 2783
  • [39] Clearing hepatitis C virus with direct antiviral agents reduces cardiovascular events in patients with prediabetes. Commentary to Sasso and colleagues
    Lonardo, Amedeo
    Mantovani, Alessandro
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (08) : 2354 - 2357
  • [40] The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital
    Sung Hwan Yoo
    Myung Kim
    Sora Kim
    Jung Il Lee
    Kwan Sik Lee
    Hyun Woong Lee
    Jin Hong Lim
    BMC Gastroenterology, 23
12345